HERCEPTIN
Solution for injection, 600mg
RxActive license
Active substance (INN)
trastuzumab
Pharmaceutical form
Pharmaceutical formSolution for injection
Strength600mg
PackagingUkupno 1 bočica staklena sa 5ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FD01)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateMarch 19, 2025
Analogs in Montenegro
2Other medicines with the same active substance
Source: CInMED register